Literature DB >> 25584916

Evaluation of angiopoietin 1 and 2, vascular endothelial growth factor, and tumor necrosis factor alpha levels in asthmatic children.

Burcu Tahire Köksal1, Ozlem Yilmaz Ozbek, Nilufer Bayraktar, Ayse Canan Yazici.   

Abstract

Asthma is characterized by chronic airway inflammation that is associated with structural changes termed airway remodeling. Recently, cytokines/mediators that augment inflammation have been attracting attention in this field. The aim of this study was to evaluate serum angiopoietin (Ang)-1, Ang-2, vascular endothelial growth factor (VEGF), and tumor necrosis factor (TNF) alpha values, which have important roles in inflammation, angiogenesis, and remodeling in asthmatic children. We also documented correlations between demographic features, duration of asthma, and pulmonary function test (PFT) parameters. Randomly selected 40 children (20 male and 20 female children, aged 6-16 years) with mild or moderate persistent asthma and 32 healthy children (15 male and 17 female children, aged 6-16 years) enrolled in the study. All asthmatic children had been using inhaled corticosteroids at least for the last 3 months. Serum Ang-1 levels were significantly lower in asthmatic children than those in normal controls. The Ang-1/Ang-2 ratio was also significantly lower in asthmatic children compared with those in normal controls (p < 0.01). However, serum Ang-2, VEGF, and TNF-alpha levels were similar in the two groups. A significant positive correlation was found between VEGF and duration of asthma. No correlation between serum Ang-1, Ang-2, VEGF values, and PFT parameters was obtained. On the other hand, significant negative correlation was detected between serum TNF-alpha and forced expiratory volume in 1 second. We have shown that serum Ang-1 levels and Ang-1/Ang-2 ratio were significantly reduced and balance was toward Ang-2 in asthmatics children. This process may lead to inflammation, destabilization of blood vessels, and trigger remodeling.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25584916     DOI: 10.2500/aap.2014.35.3793

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


  7 in total

1.  Environmental exposure, allergic disease and asthma: the distinguishing hallmark of allergy-immunology.

Authors:  Joseph A Bellanti; Russell A Settipane
Journal:  Allergy Asthma Proc       Date:  2014 Nov-Dec       Impact factor: 2.587

Review 2.  Therapeutic targeting of the angiopoietin-TIE pathway.

Authors:  Pipsa Saharinen; Lauri Eklund; Kari Alitalo
Journal:  Nat Rev Drug Discov       Date:  2017-05-19       Impact factor: 84.694

Review 3.  Meta-analysis of antenatal infection and risk of asthma and eczema.

Authors:  Tingting Zhu; Li Zhang; Yi Qu; Dezhi Mu
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

4.  Tie2 Signaling Enhances Mast Cell Progenitor Adhesion to Vascular Cell Adhesion Molecule-1 (VCAM-1) through α4β1 Integrin.

Authors:  Kazumasa Kanemaru; Emiko Noguchi; Takahiro Tokunaga; Kei Nagai; Takashi Hiroyama; Yukio Nakamura; Satoko Tahara-Hanaoka; Akira Shibuya
Journal:  PLoS One       Date:  2015-12-11       Impact factor: 3.240

5.  Angiopoietin-2 concentration in serum is associated with severe asthma phenotype.

Authors:  Joanna S Makowska; Małgorzata Cieślak; Marzanna Jarzębska; Anna Lewandowska-Polak; Marek L Kowalski
Journal:  Allergy Asthma Clin Immunol       Date:  2016-03-01       Impact factor: 3.406

Review 6.  Endothelial Activation: The Ang/Tie Axis in Sepsis.

Authors:  Aleksandra Leligdowicz; Melissa Richard-Greenblatt; Julie Wright; Valerie M Crowley; Kevin C Kain
Journal:  Front Immunol       Date:  2018-04-24       Impact factor: 7.561

Review 7.  Targeting the Angiopoietin/Tie Pathway: Prospects for Treatment of Retinal and Respiratory Disorders.

Authors:  Racheal Grace Akwii; Constantinos M Mikelis
Journal:  Drugs       Date:  2021-09-29       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.